Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AVID BIOSERVICES, INC.

(CDMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

After Hours Watch List Scorecard: CDMO, PETS, CLAR

10/26/2021 | 05:42pm EST


ę MT Newswires 2021
All news about AVID BIOSERVICES, INC.
01/10AVID BIOSERVICES : Announces Official Opening of Second Downstream Processing Suite Within..
PU
01/10AVID BIOSERVICES, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/10Avid Bioservices Announces Official Opening of Second Downstream Processing Suite Withi..
AQ
01/10Avid Bioservices Announces Official Opening of Second Downstream Processing Suite Withi..
CI
01/06INSIDER SELL : Avid Bioservices
MT
2021Craig-Hallum Adjusts Price Target on Avid Bioservices to $35 From $29, Keeps Buy Rating
MT
2021RBC Lifts Price Target on Avid Bioservices to $32 From $27, Calls Fiscal Q2 'Impressive..
MT
2021KeyBanc Downgrades Avid Bioservices to Sector Weight From Overweight
MT
2021AVID BIOSERVICES : Fiscal Q2 Earnings Snapshot
AQ
2021AVID BIOSERVICES, INC. Management's Discussion and Analysis of Financial Condition And..
AQ
More news
Analyst Recommendations on AVID BIOSERVICES, INC.
More recommendations
Financials (USD)
Sales 2022 117 M - -
Net income 2022 17,0 M - -
Net Debt 2022 - - -
P/E ratio 2022 63,8x
Yield 2022 -
Capitalization 1 073 M 1 073 M -
Capi. / Sales 2022 9,19x
Capi. / Sales 2023 7,10x
Nbr of Employees -
Free-Float -
Chart AVID BIOSERVICES, INC.
Duration : Period :
Avid Bioservices, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AVID BIOSERVICES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 17,43 $
Average target price 32,67 $
Spread / Average Target 87,4%
EPS Revisions
Managers and Directors
Nicholas S. Green President, Chief Executive Officer & Director
Daniel Ryan Hart Chief Financial Officer
Joseph Carleone Director
Nick Ferguson Executive Director-Information Technology
Richard A. Richieri Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
AVID BIOSERVICES, INC.-40.27%1 073
CSL LIMITED-14.20%84 148
WUXI BIOLOGICS (CAYMAN) INC.-19.72%41 757
ALEXION PHARMACEUTICALS, INC.0.00%40 336
SAMSUNG BIOLOGICS CO.,LTD.-18.16%39 159
BIOGEN INC.-6.13%32 161